RPS23P5

Across TCGA pan-cancer cohorts, RPS23P5 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RPS23P5 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RPS23P5 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RPS23P5 expression acts as an unfavorable survival marker, although some lineages such as UVM and LUSC show a favorable association.

UVM, CHOL, and CESC are the cancer types where RPS23P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Median	All	0.749	0.447	.001	114	view →
CHOL	OS	Tertile	All	0.024	0.728	<.001	108	view →
CESC	OS	Tertile	III,IV	0.194	0.677	.010	54	view →
ACC	OS	Tertile	All	0.133	0.686	.004	42	view →
LUSC	DFS	Tertile	All	0.863	0.624	.004	36	view →
STAD	OS	Tertile	III,IV	0.373	0.555	.027	18	view →
UCEC	OS	Tertile	All	0.328	0.705	.013	18	view →
DLBC	OS	Tertile	All	0.053	0.936	<.001	18	view →
GBM	OS	Tertile	All	0.256	0.165	.010	15	view →
PCPG	DFS	Tertile	All	0.690	0.935	.014	9	view →
KIRC	DFS	Tertile	All	0.894	0.795	.041	6	view →
LGG	DFS	Tertile	All	0.609	0.769	.035	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RPS23P5–UVM (OS)

Open the UVM breakdown →